The impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic medication in Finland

Table 6 Absolute and relative effects of the interventions to the average daily cost, estimated from the regression models

	Daily cost with intervention/-s	Daily cost without intervention/-s	Absolute change		Relative change
	Euros	Euros	Euros	95% CI	%	95% CI
Clozapine^a	1.5014	2.1430	−0.6416	−0.8355, −0.4461	−29.9	−37.6, −21.8
Olanzapine^b	1.5509	4.6046	−3.0537	−3.3425, −2.7660	−66.3	−70.7, −61.8
Quetiapine^b	3.0917	4.7482	−1.6565	−1.9443, −1.3670	−34.9	−39.8, −29.7
Risperidone^c	4.2045	7.4093	−3.2048	−3.4034, −3.0069	−43.3	−44.9, −41.5

^aIntervention: reference pricing.
^bInterventions: generic substitution and reference pricing implemented simultaneously.
^cInterventions: generic substitution and reference pricing implemented separately.

ISSN: 2191-1991